Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type

Cited in:

CrossRef

This article has been cited by:

1. 1
   Nicolino Ruperto, Pierre Quartier, Nico Wulffraat, Patricia Woo, Angelo Ravelli, Richard Mouy, Brigitte Bader-Meunier, Sebastiaan J. Vastert, Emanuele Noseda, Daniele D'Ambrosio, Jean Lecot, Abhijit Chakraborty, Alberto Martini, Andrea Chioato, A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features, Arthritis & Rheumatism, 2012, 64, 2

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(311K)
   • References
2. 2
   Todd A Kerensky, Alice B Gottlieb, Shimrat Yaniv, Shiu-chung Au, Etanercept : efficacy and safety for approved indications, Expert Opinion on Drug Safety, 2012, 11, 1, 121

   CrossRef

3. 3
   Linda Rossi-Semerano, Isabelle Koné-Paut, Is Still's Disease an Autoinflammatory Syndrome?, International Journal of Inflammation, 2012, 2012, 1

   CrossRef

4. 4
   Peter J. Gowdie, Shirley M.L. Tse, Juvenile Idiopathic Arthritis, Pediatric Clinics of North America, 2012, 59, 2, 301

   CrossRef

5. 5
   Alberto Martini, Maladie de Still de l’enfant, évolution conceptuelle et thérapeutique, Revue du Rhumatisme Monographies, 2012, 79, 1, 3

   CrossRef

6. 6
   Shabina Habibi, Athimalaipet V Ramanan, Review of biologics in children with rheumatic diseases, International Journal of Clinical Rheumatology, 2012, 7, 1, 81

   CrossRef

7. 7
   Masaaki Mori, Syuji Takei, Tomoyuki Imagawa, Hiroyuki Imanaka, Yasuhito Nerome, Rumiko Higuchi, Yoshifumi Kawano, Shumpei Yokota, Noriko Sugiyama, Hirotoshi Yuasa, Tracey Fletcher, Joseph S. Wajdula, Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan, Modern Rheumatology, 2012,

   CrossRef

8. 8
   R. Gurion, T. J. A. Lehman, L. N. Moorthy, Systemic Arthritis in Children: A Review of Clinical Presentation and Treatment, International Journal of Inflammation, 2012, 2012, 1

   CrossRef

9. 9
   M. Frosch, D. Holzinger, J. Roth, Systemische Verlaufsform der juvenilen idiopathischen Arthritis, Monatsschrift Kinderheilkunde, 2012, 160, 3, 217

   CrossRef

10. 10
    Masaki Shimizu, Yasuo Nakagishi, Kazuko Kasai, Yuichi Yamasaki, Mari Miyoshi, Syuji Takei, Akihiro Yachie, Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The diagnostic significance of interleukin-18 and interleukin-6, Cytokine, 2012, 58, 2, 287

    CrossRef

11. 11
    Andreas Reiff, Treatment of Systemic Juvenile Idiopathic Arthritis with Tocilizumab - the Role of Anti-Interleukin-6 Therapy After a Decade of Treatment, Biologics in Therapy, 2012, 2, 1

    CrossRef

12. 12
    Nina Felice Schor, Emily von Scheven, Stephen Ashwal, Swaiman's Pediatric Neurology, 2012,

    CrossRef

13. 13
    Timothy Beukelman, Nivedita M. Patkar, Kenneth G. Saag, Sue Tolleson-Rinehart, Randy Q. Cron, Esi Morgan DeWitt, Norman T. Ilowite, Yukiko Kimura, Ronald M. Laxer, Daniel J. Lovell, Alberto Martini, C. Egla Rabinovich, Nicolino Ruperto, 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features, Arthritis Care & Research, 2011, 63, 4

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(883K)
    • References
14. 14
    F. H. M. Prince, E. W. de Bekker-Grob, M. Twilt, M. A. J. van Rossum, E. P. A. H. Hoppenreijs, R. ten Cate, Y. Koopman-Keemink, S. L. Gorter, H. Raat, L. W. A. van Suijlekom-Smit, An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register, Rheumatology, 2011, 50, 6, 1131

    CrossRef

15. 15
    C. M. Hedrich, N. Bruck, B. Fiebig, M. Gahr, Anakinra: A safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA), Rheumatology International, 2011,

    CrossRef

16. 16
    Shunichiro Takezaki, Yuka Okura, Mizuho Ichikawa, Daisuke Suzuki, Junjiro Ohshima, Makoto Kaneda, Yuko Cho, Masafumi Yamada, Nobuaki Kawamura, Akihiro Iguchi, Ichiro Kobayashi, Tadashi Ariga, Development of germinoma during the treatment of systemic-onset juvenile idiopathic arthritis with infliximab, Modern Rheumatology, 2011,

    CrossRef

17. 17
    J A Snowden, R Saccardi, M Allez, S Ardizzone, R Arnold, R Cervera, C Denton, C Hawkey, M Labopin, G Mancardi, R Martin, J J Moore, J Passweg, C Peters, M Rabusin, M Rovira, J M van Laar, D Farge, Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation, Bone Marrow Transplantation, 2011,

    CrossRef

18. 18
    Michael W. Beresford, Juvenile Idiopathic Arthritis, Pediatric Drugs, 2011, 13, 3, 161

    CrossRef

19. 19
    P. Quartier, Nouveaux traitements en rhumatologie pédiatrique : impact, limites et perspectives, Archives de Pédiatrie, 2011, 18, 11, 1218

    CrossRef

20. 20
    Tomoyuki Imagawa, Shumpei Yokota, Masaaki Mori, Takako Miyamae, Syuji Takei, Hiroyuki Imanaka, Yasuhito Nerome, Naomi Iwata, Takuji Murata, Mari Miyoshi, Norihiro Nishimoto, Tadamitsu Kishimoto, Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis, Modern Rheumatology, 2011, 22, 1, 109

    CrossRef

21. 21
    Yu-Tsan Lin, Chen-Ti Wang, M. Eric Gershwin, Bor-Luen Chiang, The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis, Autoimmunity Reviews, 2011, 10, 8, 482

    CrossRef

22. 22
    Thao Pham, Hervé Bachelez, Jean-Marie Berthelot, Jacques Blacher, Yoram Bouhnik, Pascal Claudepierre, Arnaud Constantin, Bruno Fautrel, Philippe Gaudin, Vincent Goëb, Laure Gossec, Philippe Goupille, Séverine Guillaume-Czitrom, Eric Hachulla, Isabelle Huet, Denis Jullien, Odile Launay, Marc Lemann, Jean-Francis Maillefert, Jean-Pierre Marolleau, Valérie Martinez, Charles Masson, Jacques Morel, Luc Mouthon, Stanislas Pol, Xavier Puéchal, Pascal Richette, Alain Saraux, Thierry Schaeverbeke, Martin Soubrier, Anne Sudre, Tu-Anh Tran, Manuelle Viguier, Olivier Vittecoq, Daniel Wendling, Xavier Mariette, Jean Sibilia, TNF alpha antagonist therapy and safety monitoring, Joint Bone Spine, 2011, 78, 15

    CrossRef

23. 23
    Keith A. Sikora, Alexei A. Grom, Update on the pathogenesis and treatment of systemic idiopathic arthritis, Current Opinion in Pediatrics, 2011, 23, 6, 640

    CrossRef

24. 24
    Fabrizio De Benedetti, Rayfel Schneider, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

25. 25
    Norman T. Ilowite, Ronald M. Laxer, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

26. 26
    Philip J. Hashkes, Ronald M. Laxer, Rheumatology, 2011,

    CrossRef

27. 27
    Arjan J. Kwakernaak, Pieternella M. Houtman, Jan F. L. Weel, Johanna P. L. Spoorenberg, Tim L. T. A. Jansen, A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor, Clinical Rheumatology, 2010, 30, 4, 505

    CrossRef

28. 28
    W. Miehsler, G. Novacek, H. Wenzl, H. Vogelsang, P. Knoflach, A. Kaser, C. Dejaco, W. Petritsch, M. Kapitan, H. Maier, W. Graninger, H. Tilg, W. Reinisch, A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease, Journal of Crohn's and Colitis, 2010, 4, 3, 221

    CrossRef

29. 29
    Pierre Quartier, Actualités thérapeutiques des arthrites juvéniles idiopathiques, Revue du Rhumatisme, 2010, 77, A12

    CrossRef

30. 30
    Pierre Quartier, Current treatments for juvenile idiopathic arthritis, Joint Bone Spine, 2010, 77, 6, 511

    CrossRef

31. 31
    G. Dückers, T. Niehues, Die Bedeutung von Biologika bei der Therapie der SoJIA (Morbus Still), Zeitschrift für Rheumatologie, 2010, 69, 6, 505

    CrossRef

32. 32
    Claudia Macaubas, Khoa Nguyen, Chetan Deshpande, Carolyn Phillips, Ariana Peck, Tzielan Lee, Jane L. Park, Christy Sandborg, Elizabeth D. Mellins, Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states, Clinical Immunology, 2010, 134, 2, 206

    CrossRef

33. 33
    T. R. Southwood, H. E. Foster, J. E. Davidson, K. L. Hyrich, C. B. Cotter, L. R. Wedderburn, R. G. Hull, H. E. Venning, J. K. Rahman, C. L. Cummins, Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients, Rheumatology, 2010, 50, 1, 189

    CrossRef

34. 34
    Kiem Oen, Ciarán M. Duffy, Shirley M. L. Tse, Suzanne Ramsey, Janet Ellsworth, Gaëlle Chédeville, Anne-Laure Chetaille, Claire Saint-Cyr, David A. Cabral, Lynn R. Spiegel, Rayfel Schneider, Bianca Lang, Adam M. Huber, Paul Dancey, Earl Silverman, Alan M. Rosenberg, Bonnie Cameron, Nicole Johnson, Jean Dorval, Rosie Scuccimarri, Sarah Campillo, Ross E. Petty, Karen N. Watanabe Duffy, Gilles Boire, Elie Haddad, Kristin Houghton, Ronald Laxer, Stuart E. Turvey, Paivi Miettunen, Katherine Gross, Jaime Guzman, Susanne Benseler, Brian M. Feldman, Victor Espinosa, Rae S. M. Yeung, Lori Tucker, Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort, Arthritis Care & Research, 2010, 62, 4

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(171K)
    • References
35. 35
    Edward H. Giannini, Norman T. Ilowite, Daniel J. Lovell, Carol A. Wallace, C. Egla Rabinovich, Andreas Reiff, Gloria Higgins, Beth Gottlieb, Yun Chon, Nan Zhang, Scott W. Baumgartner, Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis, Arthritis & Rheumatism, 2010, 62, 11

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(193K)
    • References
36. 36
    A. D. Billiau, M. Loop, P.-Q. Le, F. Berthet, P. Philippet, A. Kasran, C. H. Wouters, Etanercept improves linear growth and bone mass acquisition in MTX-resistant polyarticular-course juvenile idiopathic arthritis, Rheumatology, 2010, 49, 8, 1550

    CrossRef

37. 37
    David C. Wilson, Anthony D. Marinov, Harry C. Blair, Daniel S. Bushnell, Susan D. Thompson, Yury Chaly, Raphael Hirsch, Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis, Arthritis & Rheumatism, 2010, 62, 8

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(207K)
    • References
38. 38
    G. Horneff, Juvenile Arthritiden, Zeitschrift für Rheumatologie, 2010, 69, 8, 719

    CrossRef

39. 39
    A. Dallocchio, D. Canioni, F. Ruemmele, A. Duquesne, J.-Y. Scoazec, R. Bouvier, F. Paraf, J. Languepin, C. H. Wouters, M. Guillot, P. Quartier, B. Bader-Meunier, Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study, Rheumatology, 2010, 49, 9, 1694

    CrossRef

40. 40
    Ukihide Tateishi, Tomoyuki Imagawa, Noriko Kanezawa, Tetsuhiko Okabe, Kazuya Shizukuishi, Tomio Inoue, Shumpei Yokota, PET assessment of disease activity in children with juvenile idiopathic arthritis, Pediatric Radiology, 2010, 40, 11, 1781

    CrossRef

41. 41
    B. Bader-Meunier, C. Wouters, C. Job-Deslandre, R. Cimaz, M. Hofer, P. Pillet, P. Quartier, Recommandations pour la prise en charge des formes oligoarticulaire et polyarticulaires (en dehors de la polyarthrite rhumatoïde) d’arthrite juvénile idiopathique, Archives de Pédiatrie, 2010, 17, 7, 1085

    CrossRef

42. 42
    Philip J. Hashkes, Yosef Uziel, Ronald M. Laxer, The safety profile of biologic therapies for juvenile idiopathic arthritis, Nature Reviews Rheumatology, 2010, 6, 10, 561

    CrossRef

43. 43
    Thao Pham, Pascal Claudepierre, Arnaud Constantin, Michel de Bandt, Bruno Fautrel, Laure Gossec, Jacques-Eric Gottenberg, Philippe Goupille, Séverine Guillaume, Eric Hachulla, Charles Masson, Jacques Morel, Xavier Puéchal, Alain Saraux, Thierry Schaeverbeke, Daniel Wendling, Eric Bruckert, Stanislas Pol, Xavier Mariette, Jean Sibilia, Tocilizumab: Therapy and safety management, Joint Bone Spine, 2010, 77, S3

    CrossRef

44. 44
    Susan Shenoi, Carol A. Wallace, Tumor Necrosis Factor Inhibitors in the Management of Juvenile Idiopathic Arthritis, Pediatric Drugs, 2010, 12, 6, 367

    CrossRef

45. 45
    Wagner L. Nedel, Dimitrios P. Kontoyiannis, Alessandro C. Pasqualotto, Aspergillosis in patients treated with monoclonal antibodies, Revista Iberoamericana de Micología, 2009, 26, 3, 175

    CrossRef

46. 46
    Kathleen Mulligan, Angela Etheridge, Laura Kassoumeri, Lucy R. Wedderburn, Stanton Newman, Do mothers and fathers hold similar views about their child's arthritis?, Arthritis Care & Research, 2009, 61, 12

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(118K)
    • References
47. 47
    J. de Inocencio Arocena, R. Merino Muñoz, C. Álvarez Madrid, J. García-Consuegra Molina, Efectividad del etanercept en el tratamiento de la artritis idiopática juvenil, Anales de Pediatría, 2009, 70, 4, 354

    CrossRef

48. 48
    Moana Sulpice, Chantal Job Deslandre, Pierre Quartier, Efficacité et tolérance d’un traitement par anti-TNF alpha chez les patients atteints de spondylarthropathies juvéniles, Revue du Rhumatisme, 2009, 76, 1, 27

    CrossRef

49. 49
    Moana Sulpice, Chantal Job Deslandre, Pierre Quartier, Efficacy and safety of TNFα antagonist therapy in patients with juvenile spondyloarthropathies, Joint Bone Spine, 2009, 76, 1, 24

    CrossRef

50. 50
    M. Halbig, G. Horneff, Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept, Rheumatology International, 2009, 30, 2, 229

    CrossRef

51. 51
    J. Le Garrec, C. Marcelli, F. Mouriaux, Les anti-Tnf peuvent-ils induire des scléro-uvéites ?, Journal Français d'Ophtalmologie, 2009, 32, 7, 511.e1

    CrossRef

52. 52
    E. H. Giannini, N. T. Ilowite, D. J. Lovell, C. A. Wallace, C. E. Rabinovich, A. Reiff, G. Higgins, B. Gottlieb, N. G. Singer, Y. Chon, S.-L. Lin, S. W. Baumgartner, Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis, Arthritis & Rheumatism, 2009, 60, 9

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(110K)
    • References
53. 53
    B. Bader-Meunier, P. Quartier, Nouveautés pharmaceutiques dans l’arthrite juvénile idiopathique, Archives de Pédiatrie, 2009, 16, 12, 1607

    CrossRef

54. 54
    G. Horneff, A. Ebert, S. Fitter, K. Minden, I. Foeldvari, J. Kummerle-Deschner, A. Thon, H. J. Girschick, F. Weller, H. I. Huppertz, Safety and efficacy of once weekly etanercept 0.8 mg/kg in a multicentre 12 week trial in active polyarticular course juvenile idiopathic arthritis, Rheumatology, 2009, 48, 8, 916

    CrossRef

55. 55
    Sebastiaan J. Vastert, Wietse Kuis, Alexei A. Grom, Systemic JIA: new developments in the understanding of the pathophysiology and therapy, Best Practice & Research Clinical Rheumatology, 2009, 23, 5, 655

    CrossRef

56. 56
    María M. Katsicas, Ricardo A. G. Russo, Use of adalimumab in patients with juvenile idiopathic arthritis refractory to etanercept and/or infliximab, Clinical Rheumatology, 2009, 28, 8, 985

    CrossRef

57. 57
    Kiran Nistala, Patricia Woo, Lucy Rachael Wedderburn, Kelley's Textbook of Rheumatology, 2009,

    CrossRef

58. 58
    Alison Kelly, Athimalaipet V Ramanan, A case of macrophage activation syndrome successfully treated with anakinra, Nature Clinical Practice Rheumatology, 2008, 4, 11, 615

    CrossRef

59. 59
    Nicolino Ruperto, Daniel J Lovell, Pierre Quartier, Eliana Paz, Nadina Rubio-Pérez, Clovis A Silva, Carlos Abud-Mendoza, Ruben Burgos-Vargas, Valeria Gerloni, Jose A Melo-Gomes, Claudia Saad-Magalhães, Flavio Sztajnbok, Claudia Goldenstein-Schainberg, Morton Scheinberg, Immaculada Calvo Penades, Michael Fischbach, Javier Orozco, Philip J Hashkes, Christine Hom, Lawrence Jung, Loredana Lepore, Sheila Oliveira, Carol A Wallace, Leonard H Sigal, Alan J Block, Allison Covucci, Alberto Martini, Edward H Giannini, Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial, The Lancet, 2008, 372, 9636, 383

    CrossRef

60. 60
    S. T. A. Roord, W. de Jager, L. Boon, N. Wulffraat, A. Martens, B. Prakken, F. van Wijk, Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+Foxp3+ regulatory T cells, Blood, 2008, 111, 10, 5233

    CrossRef

61. 61
    Kira Michalova, Lyndell Lim, Biologic agents in the management of inflammatory eye diseases, Current Allergy and Asthma Reports, 2008, 8, 4, 339

    CrossRef

62. 62
    Shumpei Yokota, Tomoyuki Imagawa, Masaaki Mori, Takako Miyamae, Yukoh Aihara, Shuji Takei, Naomi Iwata, Hiroaki Umebayashi, Takuji Murata, Mari Miyoshi, Minako Tomiita, Norihiro Nishimoto, Tadamitsu Kishimoto, Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial, The Lancet, 2008, 371, 9617, 998

    CrossRef

63. 63
    Sotirios Tsiodras, George Samonis, Dimitrios T. Boumpas, Dimitrios P. Kontoyiannis, Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy, Mayo Clinic Proceedings, 2008, 83, 2, 181

    CrossRef

64. 64
    Sotirios Tsiodras, George Samonis, Dimitrios T. Boumpas, Dimitrios P. Kontoyiannis, Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy, Mayo Clinic Proceedings, 2008, 83, 2, 181

    CrossRef

65. 65
    M Rabusin, M Andolina, N Maximova, Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives, Bone Marrow Transplantation, 2008, 41, S96

    CrossRef

66. 66
    Sheila A Doggrell, Is tocilizumab an option for the treatment of arthritis?, Expert Opinion on Pharmacotherapy, 2008, 9, 11, 2009

    CrossRef

67. 67
    P. Quartier, Maladie de Still (forme systémique d’arthrite juvénile idiopathique), Archives de Pédiatrie, 2008, 15, 5, 865

    CrossRef

68. 68
    Psychiatric Disorders with Anti-TNFalpha Treatment: An Adverse Drug Reaction to Keep in Mind, Drug Safety, 2008, 31, 10, 885

    CrossRef

69. 69
    N. Tzaribachev, J. Kuemmerle-Deschner, M. Eichner, G. Horneff, Safety and efficacy of etanercept in children with juvenile idiopathic arthritis below the age of 4 years, Rheumatology International, 2008, 28, 10, 1031

    CrossRef

70. 70
    Jan Lin, David Ziring, Sheetal Desai, Sungjin Kim, Maida Wong, Yael Korin, Jonathan Braun, Elaine Reed, David Gjertson, Ram Raj Singh, TNFα blockade in human diseases: An overview of efficacy and safety, Clinical Immunology, 2008, 126, 1, 13

    CrossRef

71. 71
    Tim Bongartz, Tocilizumab for rheumatoid and juvenile idiopathic arthritis, The Lancet, 2008, 371, 9617, 961

    CrossRef

72. 72
    Angelo Ravelli, Alberto Martini, Clinical Immunology, 2008,

    CrossRef

73. 73
    Nicolino Ruperto, Daniel J. Lovell, Ruben Cuttica, Nick Wilkinson, Patricia Woo, Graciela Espada, Carine Wouters, Earl D. Silverman, Zsolt Balogh, Michael Henrickson, Maria-Teresa Apaz, Eileen Baildam, Anders Fasth, Valeria Gerloni, Pekka Lahdenne, Anne-Marie Prieur, Angelo Ravelli, Rotraud K. Saurenmann, Maria Luz Gamir, Nico Wulffraat, Laszlo Marodi, Ross E. Petty, Rik Joos, Francesco Zulian, Deborah McCurdy, Barry L. Myones, Kalman Nagy, Peter Reuman, Ilona Szer, Suzanne Travers, Anna Beutler, Greg Keenan, Jason Clark, Sudha Visvanathan, Adedigbo Fasanmade, Aparna Raychaudhuri, Alan Mendelsohn, Alberto Martini, Edward H. Giannini, A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis, Arthritis & Rheumatism, 2007, 56, 9

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(140K)
    • References
74. 74
    C. Job-Deslandre, Artritis idiopáticas juveniles, EMC - Aparato Locomotor, 2007, 40, 3, 1

    CrossRef

75. 75
    D. M. C. Brinkman, I. M. de Kleer, R. ten Cate, M. A. J. van Rossum, W. P. Bekkering, A. Fasth, M. J. D. van Tol, W. Kuis, N. M. Wulffraat, J. M. Vossen, Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: Long-term followup of a prospective clinical trial, Arthritis & Rheumatism, 2007, 56, 7

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(182K)
    • References
76. 76
    Gerald Gartlehner, Richard A. Hansen, Beth L. Jonas, Patricia Thieda, Kathleen N. Lohr, Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence, Clinical Rheumatology, 2007, 27, 1, 67

    CrossRef

77. 77
    F. Allantaz, D. Chaussabel, D. Stichweh, L. Bennett, W. Allman, A. Mejias, M. Ardura, W. Chung, E. Smith, C. Wise, K. Palucka, O. Ramilo, M. Punaro, J. Banchereau, V. Pascual, Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade, Journal of Experimental Medicine, 2007, 204, 9, 2131

    CrossRef

78. 78
    Sasha Bernatsky, Ciaran Duffy, Peter Malleson, Debbie Ehrmann Feldman, Yvan St. Pierre, Ann E. Clarke, Economic impact of juvenile idiopathic arthritis, Arthritis Care & Research, 2007, 57, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(68K)
    • References
79. 79
    Kathleen E. Sullivan, Inflammation in Juvenile Idiopathic Arthritis, Rheumatic Disease Clinics of North America, 2007, 33, 3, 365

    CrossRef

80. 80
    Florence Allantaz, Dorothee Stichweh, Virginia Pascual, Interleukin-1 as a therapeutic target in systemic-onset juvenile idiopathic arthritis, Future Rheumatology, 2007, 2, 3, 305

    CrossRef

81. 81
    Angelo Ravelli, Alberto Martini, Juvenile idiopathic arthritis, The Lancet, 2007, 369, 9563, 767

    CrossRef

82. 82
    Pierre Quartier, Quand prescrire un anti-TNF dans les rhumatismes de l'enfant?, Revue du Rhumatisme, 2007, 74, 1, 1

    CrossRef

83. 83
    Bridgette Guthrie, Kelly A. Rouster-Stevens, Sally L. Reynolds, Review of Medications Used in Juvenile Rheumatoid Arthritis, Pediatric Emergency Care, 2007, 23, 1, 38

    CrossRef

84. 84
    Laura J Mirkinson, Ildy M Katona, Systemic onset juvenile idiopathic arthritis: update on pathogenesis and treatment, Expert Review of Clinical Immunology, 2007, 3, 3, 313

    CrossRef

85. 85
    James B. Bussel, Lisa Giulino, Susan Lee, Vivek L. Patel, Christy Sandborg, E. Richard Stiehm, Update on Therapeutic Monoclonal Antibodies, Current Problems in Pediatric and Adolescent Health Care, 2007, 37, 4, 118

    CrossRef

86. 86
    Pierre Quartier, When should we use TNF antagonists in children with rheumatic disease?, Joint Bone Spine, 2007, 74, 1, 1

    CrossRef

87. 87
    Valeria Gerloni, Irene Pontikaki, Flavio Fantini, Pediatrics in Systemic Autoimmune Diseases, 2007,

    CrossRef

88. 88
    Rayfel Schneider, Ronald M. Laxer, Pediatrics in Systemic Autoimmune Diseases, 2007,

    CrossRef

89. 89
    Michaël Hofer, Nizar Mahlaoui, Anne-Marie Prieur, A child with a systemic febrile illness – differential diagnosis and management, Best Practice & Research Clinical Rheumatology, 2006, 20, 4, 627

    CrossRef

90. 90
    Burkhard Möller, Peter M. Villiger, Inhibition of IL-1, IL-6, and TNF-α in immune-mediated inflammatory diseases, Springer Seminars in Immunopathology, 2006, 27, 4, 391

    CrossRef

91. 91
    Norihiro Nishimoto, Tadamitsu Kishimoto, Interleukin 6: from bench to bedside, Nature Clinical Practice Rheumatology, 2006, 2, 11, 619

    CrossRef

92. 92
    Andrea T. Borchers, Carlo Selmi, Gurtej Cheema, Carl L. Keen, Yehuda Shoenfeld, M. Eric Gershwin, Juvenile idiopathic arthritis, Autoimmunity Reviews, 2006, 5, 4, 279

    CrossRef

93. 93
    Giorgia Martini, Francesco Zulian, Juvenile idiopathic arthritis: current and future treatment options, Expert Opinion on Pharmacotherapy, 2006, 7, 4, 387

    CrossRef

94. 94
    Tsivia Tauber, Joseph Turetz, Judith Barash, Isaac Avni, Yair Morad, Optic Neuritis Associated With Etanercept Therapy for Juvenile Arthritis, Journal of American Association for Pediatric Ophthalmology and Strabismus, 2006, 10, 1, 26

    CrossRef

95. 95
    Petros Efthimiou, Sharon Georgy, Pathogenesis and Management of Adult-Onset Still’s Disease, Seminars in Arthritis and Rheumatism, 2006, 36, 3, 144

    CrossRef

96. 96
    Sheetal B. Desai, Daniel E. Furst, Problems encountered during anti-tumour necrosis factor therapy, Best Practice & Research Clinical Rheumatology, 2006, 20, 4, 757

    CrossRef

97. 97
    R.K. Saurenmann, A.V. Levin, B.M. Feldman, R.M. Laxer, R. Schneider, E.D. Silverman, Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFα agents, The Journal of Pediatrics, 2006, 149, 6, 833

    CrossRef

98. 98
    Michaël Hofer, Spondylarthropathies in children—are they different from those in adults?, Best Practice & Research Clinical Rheumatology, 2006, 20, 2, 315

    CrossRef

99. 99
    I M de Kleer, S Albani, B J Prakken, T-cell regulation in juvenile idiopathic arthritis, Future Rheumatology, 2006, 1, 1, 111

    CrossRef

100. 100
     Hiroshi Tanaka, Koji Tsugawa, Koichi Suzuki, Ei-shin Oki, Kazuhito Nonaka, Shigeru Kimura, Etsuro Ito, Treatment of difficult cases of systemic-onset juvenile idiopathic arthritis with tacrolimus, European Journal of Pediatrics, 2006, 166, 10, 1053

     CrossRef

101. 101
     Philip J. Hashkes, Ronald M. Laxer, Update on the medical treatment of juvenile idiopathic arthritis, Current Rheumatology Reports, 2006, 8, 6, 450

     CrossRef

102. 102
     Salih Pay, Nuran Türkçapar, Mukaddes Kalyoncu, İsmail Şimşek, Esin Beyan, İhsan Ertenli, M. Akif Öztürk, Nurşen Düzgün, Hakan Erdem, Zeynep Özbalkan, Sedat Kiraz, Gülay Kınıklı, Nesrin Besbas, Ayhan Dinç, Aşkın Ateş, Ümit Ölmez, Meral Çalgüneri, Olcay Tiryaki Aydıntuğ, Ayşin Bakkaloğlu, Mustafa Turan, Murat Turgay, Yaşar Karaaslan, Rezzan Topaloğlu, Murat Duman, Seza Özen, A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis, Clinical Rheumatology, 2005, 25, 5, 639

     CrossRef

103. 103
     Tsutomu Takeuchi, Kouichi Amano, Hideto Kameda, Toru Abe, Anti-TNF Biological Agents in Rheumatoid Arthritis and Other Inflammatory Diseases, Allergology International, 2005, 54, 2, 191

     CrossRef

104. 104
     R. E. Hough, J. A. Snowden, N. M. Wulffraat, Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective, British Journal of Haematology, 2005, 128, 4

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(285K)
     • References
105. 105
     David J. Rychly, Joseph T. DiPiro, Infections Associated with Tumor Necrosis Factor-α Antagonists, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005, 25, 9

     Direct Link:

     • Abstract
     • PDF(114K)
     • References
106. 106
     Kathleen E. Sullivan, Inflammation in Juvenile Idiopathic Arthritis, Pediatric Clinics of North America, 2005, 52, 2, 335

     CrossRef

107. 107
     Earl Silverman, Lynn Spiegel, David Hawkins, Ross Petty, Donald Goldsmith, Laura Schanberg, Ciaran Duffy, Paul Howard, Vibeke Strand, Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis, Arthritis & Rheumatism, 2005, 52, 2

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(151K)
     • References
108. 108
     G. Horneff, Stellenwert der neuen Biologicals und Zytokinantagonisten in der Therapie der juvenilen idiopathischen Arthritis (JIA), Zeitschrift für Rheumatologie, 2005, 64, 5, 317

     CrossRef

109. 109
     Fabrizio de Benedetti, Alberto Martini, Targeting the interleukin-6 receptor: A new treatment for systemic juvenile idiopathic arthritis?, Arthritis & Rheumatism, 2005, 52, 3

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(79K)
     • References
110. 110
     Chicky Dadlani, Seth J. Orlow, Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: Review of the dermatologic and rheumatologic literature, Journal of the American Academy of Dermatology, 2005, 52, 2, 316

     CrossRef

111. 111
     N M Wulffraat, B Vastert, A Tyndall, Treatment of refractory autoimmune diseases with autologous stem cell transplantation: focus on juvenile idiopathic arthritis, Bone Marrow Transplantation, 2005, 35, S27

     CrossRef

112. 112
     Thomas G. Mason, Ann M. Reed, Update in juvenile rheumatoid arthritis, Arthritis Care & Research, 2005, 53, 5

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(67K)
     • References
113. 113
     P. Quartier, A.-M. Prieur, Arthrites juvéniles idiopathiques, EMC - Médecine, 2004, 1, 6, 555

     CrossRef

114. 114
     F. M. Ruemmele, A-M. Prieur, C. Talbotec, O. Goulet, J. Schmitz, Development of Crohn Disease During Anti???TNF-?? Therapy in a Child With Juvenile Idiopathic Arthritis, Journal of Pediatric Gastroenterology and Nutrition, 2004, 39, 2, 203

     CrossRef

115. 115
     Roy Fleischmann, Richard Stern, Imran Iqbal, Etanercept - review of efficacy and safety after five years of clinical use, Therapy, 2004, 1, 1, 11

     CrossRef

116. 116
     Roy Fleischmann, Richard Stern, Imran Iqbal, Etanercept – review of efficacy and safety after five years of clinical use, Therapy, 2004, 1, 1, 11

     CrossRef

117. 117
     Melissa Amy Magliocco, Alice Bendix Gottlieb, Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: Report of 3 cases, Journal of the American Academy of Dermatology, 2004, 51, 4, 580

     CrossRef

118. 118
     Dirk Foell, Helmut Wittkowski, Inga Hammerschmidt, Nico Wulffraat, Heinrike Schmeling, Michael Frosch, Gerd Horneff, Wietse Kuis, Clemens Sorg, Johannes Roth, Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations, Arthritis & Rheumatism, 2004, 50, 4

     Direct Link:

     • Abstract
     • Full Article (HTML)
     • PDF(186K)
     • References
119. 119
     Nico M Wulffraat, Ismee M de Kleer, Berent J Prakken, Wietse Kuis, Refractory juvenile idiopathic arthritis, Best Practice & Research Clinical Haematology, 2004, 17, 2, 277

     CrossRef

120. 120
     Peter C Taylor, Richard O Williams, Marc Feldmann, Tumour necrosis factor α as a therapeutic target for immune-mediated inflammatory diseases, Current Opinion in Biotechnology, 2004, 15, 6, 557

     CrossRef

121. 121
     Lucila M. A. Agle, Liza B. Vazquez-Cobian, Thomas J. A. Lehman, Clinical trials in pediatric uveitis, Current Rheumatology Reports, 2003, 5, 6, 477

     CrossRef

122. 122
     Brandt P. Groh, Current concepts in pediatric rheumatology, Current Opinion in Orthopaedics, 2003, 14, 6, 385

     CrossRef

123. 123
     Pierre Quartier, Modalités actuelles de la prise en charge thérapeutique des arthrites juvéniles idiopathiques, Revue du Rhumatisme, 2003, 70, 6, 500

     CrossRef

124. 124
     Peter Chira, Christy I. Sandborg, Novel therapies in pediatric rheumatic diseases, Current Opinion in Pediatrics, 2003, 15, 6, 579

     CrossRef

125. 125
     Roy Fleischmann, Safety and efficacy of disease-modifying antirheumatic agents in rheumatoid arthritis and juvenile rheumatoid arthritis, Expert Opinion on Drug Safety, 2003, 2, 4, 347

     CrossRef

126. 126
     Polly Livermore, Clarissa Pilkington, The Use of Emerging Biological Treatments in Children,

     Direct Link:

     • Summary
     • PDF(186K)
     • References